Notably, IFNG + tumor cells alone did not reach statistical significance when compared between resistant lesions and pretreatment samples, yet the IFN + tumor cell–enriched CN showed significant differences, underscoring that individual cell types do not function in isolation.
← all excerpts
Tumor cell-derived IFN spatially reprograms osteopontin-enriched macrophage niches to promote PARP inhibitor resistance.
1
—
—